Lilly confirms date and conference call for second-quarter 2025 financial results announcementPRNewsWire • 07/24/25
This Weight-Loss Stock Sank After Earnings. It's Still a Risk for Eli Lilly, Novo Nordisk.Barrons • 07/24/25
Gate Bioscience Enters into a Collaboration and License Agreement with Lilly to Discover and Develop Molecular Gate MedicinesBusiness Wire • 07/24/25
3 Healthcare Stocks to Buy Before They Announce Game-Changing Clinical Trial ResultsThe Motley Fool • 07/22/25
15 stocks of companies set to grow sales twice as fast as the S&P 500 — analysts love themMarket Watch • 07/21/25
Industry-Wide Tariffs Loom Over the Healthcare Sector. Here Are 2 Stocks That Can Weather the Storm.The Motley Fool • 07/20/25
Brokers Suggest Investing in Lilly (LLY): Read This Before Placing a BetZacks Investment Research • 07/18/25
Can Eli Lilly Stock Withstand the Threat of President Trump's New Sweeping Tariffs?The Motley Fool • 07/18/25
Eli Lilly vs. Merck: Which Drug Giant Appears Better Poised Today?Zacks Investment Research • 07/17/25
Eli Lilly (NYSE: LLY) Stock Price Prediction and Forecast 2025-2030 (July 2025)24/7 Wall Street • 07/14/25
Can Mounjaro and Zepbound Drive Another Strong Quarter for Eli Lilly?Zacks Investment Research • 07/11/25
Eli Lilly (LLY) Beats Stock Market Upswing: What Investors Need to KnowZacks Investment Research • 07/09/25
Eli Lilly Q2 preview: BofA sees focus on policy risks, obesity pipelineProactive Investors • 07/09/25